BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic fatty liver disease
1
Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
12/31/2019 7:02:25 AM | Browse: 32 | Download: 42
2
LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
12/6/2019 8:06:37 AM | Browse: 33 | Download: 17
3
MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes
11/14/2019 9:43:48 AM | Browse: 47 | Download: 38
4
Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
9/30/2019 2:14:06 AM | Browse: 103 | Download: 61
5
Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
9/12/2019 8:50:34 AM | Browse: 44 | Download: 43
6
Exhaled breath analysis in hepatology: State-of-the-art and perspectives
8/14/2019 1:31:33 PM | Browse: 61 | Download: 59
7
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 78 | Download: 50
8
Freeze-dried Si-Ni-San powder can ameliorate high-fat-diet-induced non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 128 | Download: 107
9
Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis
4/26/2019 3:40:00 AM | Browse: 150 | Download: 146
10
Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
4/13/2019 6:00:06 AM | Browse: 134 | Download: 149
11
Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents
3/28/2019 9:14:41 AM | Browse: 147 | Download: 116
12
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 133 | Download: 98
13
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 135 | Download: 69
14
Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model
12/7/2018 3:57:11 AM | Browse: 168 | Download: 122
15
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
11/27/2018 1:56:41 PM | Browse: 168 | Download: 120
16
Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease
10/17/2018 8:55:58 AM | Browse: 133 | Download: 135
17
PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease
9/26/2018 9:00:43 AM | Browse: 246 | Download: 134
18
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 272 | Download: 133
19
Associations between nonalcoholic fatty liver disease and ischemic stroke
7/27/2018 4:31:20 PM | Browse: 198 | Download: 153
20
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
7/19/2018 7:04:34 AM | Browse: 201 | Download: 120
21
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
6/15/2018 9:13:16 AM | Browse: 183 | Download: 124
22
Mediterranean diet and nonalcoholic fatty liver disease
5/18/2018 2:03:19 AM | Browse: 280 | Download: 177
23
Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
5/18/2018 2:03:19 AM | Browse: 265 | Download: 106
24
Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
5/11/2018 10:51:26 AM | Browse: 209 | Download: 106
25
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 253 | Download: 182
26
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
4/11/2018 8:28:49 AM | Browse: 319 | Download: 160
27
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 286 | Download: 154
28
Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data
1/26/2018 8:09:36 AM | Browse: 317 | Download: 159
29
Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
1/26/2018 2:31:05 AM | Browse: 275 | Download: 122
30
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 319 | Download: 177
31
Palmitate induces fat accumulation by activating C/EBPβ-mediated G0S2 expression in HepG2 cells
11/20/2017 4:03:35 AM | Browse: 357 | Download: 256
32
Nonalcoholic fatty liver disease: Evolving paradigms
9/26/2017 12:18:54 AM | Browse: 488 | Download: 313
33
New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase Ⅱ trial
8/28/2017 6:54:48 AM | Browse: 337 | Download: 221
34
Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
8/14/2017 1:56:00 AM | Browse: 271 | Download: 280
35
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease
6/14/2017 9:25:57 AM | Browse: 342 | Download: 293
36
Nonalcoholic fatty liver disease: Diagnostic biomarkers
5/16/2017 6:56:36 AM | Browse: 457 | Download: 557
37
Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
4/20/2017 3:58:56 PM | Browse: 742 | Download: 824
38
Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma
4/20/2017 3:58:56 PM | Browse: 381 | Download: 420
39
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
2/26/2017 6:20:00 PM | Browse: 542 | Download: 605
40
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 445 | Download: 536
41
bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research
11/25/2016 9:02:00 AM | Browse: 546 | Download: 461
42
Nonalcoholic fatty liver disease - A multisystem disease?
11/18/2016 3:13:00 PM | Browse: 593 | Download: 557
43
Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
11/6/2016 3:43:00 PM | Browse: 324 | Download: 378
44
Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
11/6/2016 3:43:00 PM | Browse: 567 | Download: 295
45
Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
10/26/2016 5:33:00 PM | Browse: 394 | Download: 478
46
Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis
10/20/2016 5:06:00 PM | Browse: 678 | Download: 411
47
Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease
9/8/2016 10:53:00 AM | Browse: 509 | Download: 847
48
Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development
8/23/2016 6:33:00 PM | Browse: 460 | Download: 583
49
Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?
8/15/2016 10:30:00 AM | Browse: 503 | Download: 471
50
Metabolic aspects of adult patients with nonalcoholic fatty liver disease
8/15/2016 10:30:00 AM | Browse: 828 | Download: 457
Write to the Help Desk
© 2004-2020 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345